Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circular RNAs in vascular diseases. | Front Cardiovasc Med | 2023 | 37840954 | PubTator, text mining | PubMed |
| Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy. | Ophthalmol Ther | 2023 | 37837578 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. | Cancers (Basel) | 2023 | 37835573 | PubTator, text mining | PubMed |
| Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia. | Int J Mol Sci | 2023 | 37833857 | PubTator, text mining | PubMed |
| MicroRNAs in atrial fibrillation target genes in structural remodelling. | Cell Tissue Res | 2023 | 37833432 | PubTator, text mining | PubMed |
| Impact of the Physical Cellular Microenvironment on the Structure and Function of a Model Hepatocyte Cell Line for Drug Toxicity Applications. | Cells | 2023 | 37830622 | PubTator, text mining | PubMed |
| Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway. | Front Pharmacol | 2023 | 37829301 | PubTator, text mining | PubMed |
| CD98 heavy chain as a prognostic biomarker and target for cancer treatment. | Front Oncol | 2023 | 37823053 | PubTator, text mining | PubMed |
| Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis. | Mol Cell Proteomics | 2023 | 37820923 | PubTator, text mining | PubMed |
| Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential. | MedComm (2020) | 2023 | 37799806 | PubTator, text mining | PubMed |
| Electric field promotes dermal fibroblast transdifferentiation through activation of RhoA/ROCK1 pathway. | Int J Med Sci | 2023 | 37786441 | PubTator, text mining | PubMed |
| HCMV UL8 interaction with β-catenin and DVL2 regulates viral reactivation in CD34+ hematopoietic progenitor cells. | J Virol | 2023 | 37772824 | PubTator, text mining | PubMed |
| Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma. | Onco Targets Ther | 2023 | 37771939 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Apoptosis, TNF Alpha and Interferon Gamma Response Gene mRNA Expression in T Lymphocytes. | Int J Mol Sci | 2023 | 37761990 | PubTator, text mining | PubMed |
| TGF-β2 Induces Epithelial-Mesenchymal Transitions in 2D Planer and 3D Spheroids of the Human Corneal Stroma Fibroblasts in Different Manners. | Biomedicines | 2023 | 37760954 | PubTator, text mining | PubMed |
| Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease. | Biomedicines | 2023 | 37760774 | PubTator, text mining | PubMed |
| Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension. | J Cell Mol Med | 2023 | 37753829 | PubTator, text mining | PubMed |
| TIPE2 ameliorates neuroinflammation and cognitive impairment in sepsis-associated encephalopathy through regulating RhoA/ROCK2-NF-κB signaling pathway. | Biochem Pharmacol | 2023 | 37748665 | PubTator, text mining | PubMed |
| The Mechanics of Tumor Cells Dictate Malignancy via Cytoskeleton-Mediated APC/Wnt/β-Catenin Signaling. | Research (Wash D C) | 2023 | 37746658 | PubTator, text mining | PubMed |
| Network pharmacology combined with molecular docking and in vitro verification reveals the therapeutic potential of Delphinium roylei munz constituents on breast carcinoma. | Front Pharmacol | 2023 | 37724182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=18